CRISPR/Cas9 genome editing to treat sickle cell disease
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Κύριος συγγραφέας: | Ullah, Mohammad |
---|---|
Άλλοι συγγραφείς: | Islam, Farzana |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
Brac University
2023
|
Θέματα: | |
Διαθέσιμο Online: | http://hdl.handle.net/10361/19355 |
Παρόμοια τεκμήρια
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
ανά: Maria, Amatul
Έκδοση: (2020) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
ανά: Shaikat, Mahdi Mubin
Έκδοση: (2023) -
A review on CRISPR-Cas system based applications in Oncology
ανά: Sadia, Mir
Έκδοση: (2022) -
A review on CRISPR Technology as an Antiviral Tool
ανά: Srishti, Sanjida Ahmed
Έκδοση: (2023) -
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
ανά: Eva, Israt Ara Jannat
Έκδοση: (2023)